E/M Coding Alert - 2006 Issue 7
PART D: Plan Formularies Fail To Provide Dual Eligibles With Access To Critical Meds
Subscribe or sign in to view the full article.
Article Overview
This article summarizes an HHS Office of Inspector General report about how Medicare Part D formularies affect dual eligibles’ access to prescription drugs. It focuses on broad formulary coverage patterns, statutory exclusions, transition provisions intended to help beneficiaries move from Medicaid to Medicare drug coverage, and CMS’s critique of the report’s scope and methodology. The piece is relevant to health plans, Medicare and Medicaid stakeholders, compliance professionals, and coding/reimbursement readers tracking policy changes that affect drug coverage access.
Why This Topic Matters
It highlights how formulary design and coverage policy can affect vulnerable beneficiaries who are transitioning between Medicaid and Medicare. Readers can use it to understand the general policy and administrative issues behind Part D drug access and the role of federal oversight.
Article Sections
-
Broad Distribution Among Formularies Dilutes Drugs' Availability
Discusses the overall distribution of drug coverage across Medicare Part D formularies and how coverage varies among plans and regions. It also describes general transition-related safeguards available to beneficiaries.
-
Statutory Exclusions Keep Some Drugs Under Medicaid
Covers the article’s discussion of excluded drug categories and how state Medicaid programs may continue to provide coverage for some affected drugs. It also summarizes the scope of state-level coverage mentioned in the report.
-
CMS Challenges OIG's Scope And Methodology
Summarizes CMS’s response to the OIG report, including concerns about the report’s methodology and the agency’s separate analysis of formulary coverage.
What You Will Learn
- How an OIG report evaluated drug coverage across Medicare Part D formularies
- What general coverage patterns were described for dual eligibles
- How transition assistance and formulary exception processes were discussed
- What role statutory exclusions and Medicaid coverage play in the article’s policy discussion
- How CMS responded to the report’s methodology and findings
Who Should Read This
- Medicare policy analysts
- Medicaid stakeholders
- Health plan administrators
- Compliance professionals
- Coding and reimbursement professionals
- Healthcare attorneys
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com